Wealthcare Advisory Partners’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,578
Closed 710
2022
Q3
$0 Hold
11,578
﹤0.01% 636
2022
Q2
$4K Buy
+11,578
New +$4K ﹤0.01% 562